Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Nadine Al-Naamani, MD, MS

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Attending physician, Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Attending physician, Hospital of the University of Pennsylvania
Attending physician, Penn Presbyterian Medical Center
Instructor A in Medicine, University of Pennsylvania Perelman School of Medicine, Department of Medicine
Department: Medicine

Contact information
9045 Gates Building
3600 Spruce Street
Philadelphia, PA 19104
Education:
BS (Chemistry)
American University of Beirut, 1999.
MD (Medicine)
American University of Beirut, 2003.
MS (Clinical and Translational Science)
Sackler School of Graduate Biomedical Sciences at Tufts University, 2016.
Post-Graduate Training
Internship and Residency, Internal Medicine, American University of Beirut, 2003-2006.
Postdoctoral Research Scientist, Pulmonary, Allergy and Critical Care Medicine, Columbia University College of Physicians and Surgeons, 2006-2008.
Internship, Internal Medicine, St. Luke's Roosevelt Hospital, 2008-2009.
Residency, Internal Medicine, St. Luke's Roosevelt Hospital, 2009-2010.
Residency, Medicine, Cambridge Health Alliance, 2010-2011.
Fellowship, Pulmonary and Critical Care Medicine, Tufts Medical Center, 2011-2014.
Fellowship, Comparative Effectiveness Research, Tufts Clinical and Translational Science Institute, 2014-2016.
Certifications
Permanent Certificate, Educational Commission on Foreign Medical Graduates, 2007.
American Board of Internal Medicine, Internal Medicine, 2011.
American Board of Internal Medicine, Pulmonary Disease, 2013.
Basic Life Support (BLS) Provider, 2014.
Advanced Cardiovascular Life Support (ACLS) Provider, 2014.
American Board of Internal Medicine, Critical Care, 2014.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Pulmonary vascular disease research

Selected Publications

S. Narasimmal, S. Pugliese, T. M. Bull, T. De Marco, J. W. McConnell, M. R. Lammi, T. Thenappan, J. P. Feldman, J. S. Sager, D. B. Badesch, J. J. Ryan, D. Grinnan, D. Zwicke, E. Horn, J. M. Elwing, J. Robinson, J. E. Moss, M. Eggert, O. A. Shlobin, R. P. Frantz, S. Bartolome, S. C. Mathai, S. Mazimba, N. Al-Naamani: Quality Of Life Of Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH) And Idiopathic Pulmonary Arterial Hypertension (IPAH): The Pulmonary Hypertension Association Registry (PHAR). American Thoracic Society International Conference May 2020.

Min J, Feldman J, Sager J, Shlobin O, McConnell JW, Lammi M, Frantz R, Ventetuolo C, Klinger J, Zamanian R, Robinson J, Elwing J, Badesch D, Thenappan T, Simon M, Ryan J, Mazimba S, Grinnan D, Chakinala M, Horn E, Al-Naamani N: Risk Prediction Models Are Associated With Patient Centered Outcomes In PAH: The Pulmonary Hypertension Association Registry American Thoracic Society International Conference May 2020.

J Min, DH Appleby, RL McClelland, JH Holmes, RJ Urbanowicz, CA Burwell, CL Archer-Chicko, SC Pugliese, JA Mazurek, KA Smith, JS Fritz, HI Palevsky, SM Kawut, N Al-Naamani: Secular Trends In Subject Characteristics Of Pulmonary Arterial Hypertension Clinical Trials. American Thoracic Society International Conference May 2020.

Rochon Elizabeth R, Krowka Michael J, Bartolome Sonja, Heresi Gustavo A, Bull Todd, Roberts Kari, Hemnes Anna, Forde Kimberly A, Krok Karen L, Patel Mamta, Lin Grace, McNeil Megan, Al-Naamani Nadine, Roman Beth L, Yu Paul B, Fallon Michael B, Gladwin Mark T, Kawut Steven M: BMP 9/10 in Pulmonary Vascular Complications of Liver Disease. American journal of respiratory and critical care medicine Feb 2020.

N Al-Naamani, H-M Pan, MR Anderson, DA Torigian, Y Tong, M Oyster, MK Porteous, S Palmer, SM Arcasoy, JM Diamond, JK Udupa, JD Christie, DJ Lederer, and SM Kawut: Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates: The Lung Transplant Body Composition Study. Annals of the American Thoracic Society 2020 Notes: In press.

Al-Naamani N, Krowka MJ, Forde KA, Krok KL, Feng R, Heresi GA, Dweik RA, Bartolome S, Bull TM, Roberts KE, Austin ED, Hemnes AR, Patel MJ, Oh JK, Lin G, Doyle MF, Denver N, Andrew R, MacLean MR, Fallon, MB#, Kawut SM#; Pulmonary Vascular Complications of Liver Disease Study Group. : Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2). Hepatology 2020 Notes: In press.

Al-Naamani Nadine, Ventetuolo Corey E: Another Piece in the Estrogen Puzzle of Pulmonary Hypertension. American journal of respiratory and critical care medicine 201(3): 274-275, Nov 2019.

Kawut Steven M, Pinder Diane, Al-Naamani Nadine, McCormick Amber, Palevsky Harold I, Fritz Jason, Smith K Akaya, Mazurek Jeremy A, Doyle Margaret F, MacLean Margaret R, DeMichele Angela, Mankoff David A: Fulvestrant for the Treatment of Pulmonary Arterial Hypertension. Annals of the American Thoracic Society 16(11): 1456-1459, Jul 2019.

H. Pan, M. Anderson, J. Diamond, S. Palmer, M. Oyster, D. Torigian, M. Porteous, S. Arcasoy, Y. Tong, J. Udupa, J. Christie, S. M. Kawut, D. Lederer, N. Al-Naamani. : Subcutaneous adipose tissue is associated with presence of pulmonary hypertension in advanced lung disease. American Thoracic Society International Conference May 2019.

Bhardwaj, A., Al-Naamani, N., Pinder, D., Boyle, K., McCormick, A., Patel, M., Burwell, C.A., Smith, A., Mazurek, J.A., Archer-Chicko, C.L., Palevsky, H.I., Fritz, J.S., Pugliese, S., Kawut, S. M. : Changing Demographics of Patients with Idiopathic Pulmonary Arterial Hypertension (IPAH). American Thoracic Society International Conference May 2019.

back to top
Last updated: 06/15/2020
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with a supported browser.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration